Participated · Series A · Jan 2026

Evaro is an NHS-licensed digital healthcare platform founded by medical professionals to embed regulated online care within consumer brands’ existing digital experiences. Its healthcare-as-a-service stack covers asynchronous consultations, remote diagnostics, prescribing, dispensing and aftercare, and can be integrated in a short timeframe with minimal engineering lift for partners. The system supports treatment across more than 80 common conditions and has already served over two million patients through various consumer-facing brands. By enabling trusted non-clinical companies to add healthcare offerings, Evaro creates new revenue streams and deeper customer engagement while helping relieve pressure on overstretched UK primary care. The company generates income from these brand partnerships, though detailed revenue figures were not disclosed. With fresh capital in hand, Evaro intends to expand its reach and further develop its infrastructure for the UK market. The new funding round signals investor confidence in the firm’s traction and its ability to scale regulated digital healthcare delivery.

Led · Series A · Nov 2024

PocDoc develops a proprietary smartphone-based platform that enables patients to perform rapid diagnostic tests for cardiovascular, metabolic and renal screenings in workplaces, communities and at home, delivering fast results. Its flagship 'Healthy Heart Check' allows cardiovascular screenings with results viewable via the NHS app. The company has partnerships with the NHS and private-sector partners including Asda, Pharmacy2U and Lincolnshire Co-op Pharmacy. Tens of thousands of patients have used the service and 97% report they would recommend it to family and friends. PocDoc says it has new tests for metabolic, kidney and whole-body health in the pipeline and plans to scale into new international markets next year. Financially, the company completed a €5.9 million pre-A funding round—the reportedly largest at this stage for a UK digital diagnostics company—which will support rapid growth and commercialization.

Participated · Equity · Feb 2024

Vitrue Health operates a digital musculoskeletal (MSK) health platform for workplaces that uses computer vision and biomechanical analysis to deliver workplace health assessments that are accurate, holistic and personalised. The platform aims to reduce musculoskeletal pain and help employers fulfil regulatory obligations at scale. It is used by customers including Bupa, the NHS, Hastings Direct and Campari. Led by CEO Shane Lowe, the London-based technology startup specialises in reducing musculoskeletal pain and supporting workplace health. The company raised $4M in a recent funding round, bringing its total funding to $7M. Vitrue plans to use the proceeds to grow the team and advance expansion across the US and into new European markets.

Led · Series A · Apr 2023

Scan.com operates an online referral and booking platform that lets patients self-refer or book scans with partnered private imaging centers (MRI, ultrasound, CT, X-ray) and receive clinician consultations and user-friendly reports. Users pay up-front, are offered a virtual clinician consultation within 48 hours, and typically receive reports within a week; if a clinician deems a scan unjustified Scan.com refunds the fee (about 3% of cases). Pricing cited ranges roughly from £180–£395 or more and can include consultation, scan and follow-up reports. The company runs an “urgent findings pathway” to contact patients and their doctors when serious problems are identified. Scan.com currently claims around 30 employees across the U.K. and U.S. and reported it ramped to $1 million in annualized revenue in the first five weeks after its recent U.S. launch. Plans for growth include expanding to additional U.S. states, adding modalities such as DEXA scans, echocardiograms and mammograms (including early mammogram screenings targeting women under 50), and pursuing enterprise contracts with digital health providers and employee benefit platforms. Scan.com provides a booking portal and proprietary API to remove administrative friction and allow clinicians, consultants and digital health providers to refer patients for imaging. The platform integrates supply from over 200 imaging centres and claims to cut diagnostic wait times to about a week, roughly one-third of the NHS average. Scan.com plans to expand its diagnostics-as-a-service proposition in the U.S. and Germany and to rapidly scale its B2B platform in the U.K. It intends to introduce new products for medicolegal, health insurance and telehealth providers. The company has raised a £2.0 million seed round last year and has angel backers including Evelyn Bourke and Tom Blomfield. The latest funding is positioned to speed up booking and results delivery and help imaging centres transition to a post-COVID-19 digital model.

Participated · Series B · Jan 2023

Founded in London in 2018, Peppy offers employer-funded, individualized health services around menopause, fertility, pregnancy and early parenthood delivered through a mobile app. Employees access experts via instant messaging, group chat, video consultations, live events, articles, videos, programs and communities. The service emphasizes one-to-one support such as personal video consultations and has expanded to cover endometriosis and PCOS. Peppy sells to corporate customers who then offer the service free to employees; clients include Accenture, Adobe, Canada Life, Disney and Marsh McLennan. Management says the company already dominates Europe’s employer-funded gender-based healthcare market and is using new capital to scale internationally. The company cites broader tailwinds including digitization of healthcare and rising demand as drivers of growth, referencing a $15.4B global menopause market and projected continued growth. Peppy offers a digital, expert-led health platform focused on major life and family moments: menopause, fertility, pregnancy and early parenthood. Its services are delivered through a secure mobile app with instant messaging, group chat, video consultations, live events, evidence-based articles, videos, structured programs and peer communities. Peppy sells to employers who integrate the service into employee health and benefits programs, citing customers such as BNP Paribas, Santander, DFS, Wickes, NHS trusts and the University of Sheffield. The company reports growth of about 20% month-over-month for the past 12 months. Peppy was founded in London in 2018 and is positioning itself to expand employer adoption as awareness and demand for targeted employee benefits accelerates. The founders say the product aims to provide personalized, long-term support that helps employees navigate options and return to work, beyond what typical GP visits or one-size-fits-all policies offer. Peppy offers employers a platform that connects employees with accredited experts for one-to-one chat support, mental health practitioners, moderated peer group chats, online group exercises and bespoke phone and video consultations (e.g., breastfeeding, baby sleep, menopause). The service is aimed at supporting people through critical life transitions and strengthening workforce resilience. All experts on the platform have completed accredited training and meet relevant professional-body requirements. Peppy is already working with a wide range of employers and is currently available to employees in the UK only. The company plans to expand its team and the platform, adding new fertility and expanded mental-health support. Funding will be used to grow tech, product, marketing and sales functions to support that expansion.